Surmodics Inc.

NASDAQ: SRDX · Real-Time Price · USD
38.26
0.62 (1.65%)
At close: Aug 15, 2025, 12:27 PM

Surmodics Income Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Revenue
126.08M 132.58M 99.95M 105.14M
Cost of Revenue
33.03M 71.56M 70.95M 63.91M
Gross Profit
93.05M 61.02M 29M 41.23M
Operating Income
-5.64M 5.15M -22.1M 6.7M
Interest Income
n/a n/a n/a n/a
Pretax Income
-7.51M 2.49M -22.49M 6.35M
Net Income
-11.54M -1.54M -27.27M 4.24M
Selling & General & Admin
56.84M 51.88M 46.95M 30.68M
Research & Development
10M 9.57M 9.08M 46.73M
Other Expenses
31.86M 41.01M -4.93M 3.34M
Operating Expenses
98.7M 102.47M 51.1M 80.76M
Interest Expense
3.54M 3.49M 598K 310K
Selling & Marketing Expenses
n/a n/a 12K 3K
Cost & Expenses
131.72M 126.98M 122.05M 98.43M
Income Tax Expense
4.04M 4.02M 4.78M 2.11M
Shares Outstanding (Basic)
14.15M 14.03M 13.92M 13.77M
Shares Outstanding (Diluted)
14.15M 14.03M 13.92M 13.99M
EPS (Basic)
-0.82 -0.11 -1.96 0.31
EPS (Diluted)
-0.82 -0.11 -1.96 0.30
EBITDA
4.73M 15.15M -12.22M 14.67M
EBIT
-3.97M 5.98M -21.89M 6.66M
Depreciation & Amortization
8.69M 9.17M 9.67M 8.02M